{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:16:05Z","timestamp":1784672165000,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00284-026-04757-w","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:28:53Z","timestamp":1771421333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage-targeted Hyaluronic-acid Coated Liposomes Bearing Ursolic Acid for Visceral Leishmaniasis: In Vitro Characterisation and Pharmacokinetic Analysis"],"prefix":"10.1007","volume":"83","author":[{"given":"Spandana","family":"Gollapalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyal","family":"Sayyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Devangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Chandanpalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandkumar","family":"Doijad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-7667","authenticated-orcid":false,"given":"Jitender","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"4757_CR1","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.microb.2025.100239","volume":"6","author":"N Makarani","year":"2025","unstructured":"Makarani N, Bharadava K, Kaushik A et al (2025) Leishmaniasis: A multifaceted approach to diagnosis, maladies, drug repurposing and way forward. Microbe 6:100239","journal-title":"Microbe"},{"key":"4757_CR2","doi-asserted-by":"publisher","first-page":"102999","DOI":"10.1016\/j.parint.2024.102999","volume":"105","author":"H Kato","year":"2025","unstructured":"Kato H (2025) Epidemiology of leishmaniasis: risk factors for its pathology and infection. Parasitol Int 105:102999","journal-title":"Parasitol Int"},{"key":"4757_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1208\/s12249-023-02507-w","volume":"24","author":"P Pingle","year":"2023","unstructured":"Pingle P, Mourya A, Namdeo M et al (2023) Andrographolide-Soya-L-\u03b1-Phosphatidyl choline complex augmented solubility and drug delivery in leishmania donovani, a causative agent for cutaneous and visceral leishmaniasis. AAPS PharmSciTech 24:46","journal-title":"AAPS PharmSciTech"},{"key":"4757_CR4","doi-asserted-by":"crossref","unstructured":"Gollapalli S, Bajad G, Brahma U et al (2026) Stearylamine enriched lipid-polymer hybrid nanoparticles of ursolic acid for targeting leishmania donovani: In-vitro studies. Glycosci Ther 2:100024","DOI":"10.1016\/j.glycos.2025.100024"},{"key":"4757_CR5","doi-asserted-by":"publisher","first-page":"111120","DOI":"10.1016\/j.biopha.2020.111120","volume":"134","author":"GS Ramos","year":"2021","unstructured":"Ramos GS, Vallejos VMR, Ladeira MS et al (2021) Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis. Biomed Pharmacother 134:111120","journal-title":"Biomed Pharmacother"},{"key":"4757_CR6","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.4155\/fmc-2018-0512","volume":"11","author":"GM das Neves","year":"2019","unstructured":"das Neves GM, Kagami LP, Gon\u00e7alves IL, Eifler-Lima VL (2019) Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery. Future Med Chem 11:2107\u20132130","journal-title":"Future Med Chem"},{"key":"4757_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1021\/acsomega.4c06146","volume":"10","author":"O de Viana","year":"2024","unstructured":"de Viana O, Weber J, da Cruz KC LEG, et al (2024) In Silico structural insights and potential inhibitor identification based on the benzothiazole core for targeting leishmania major pteridine reductase 1. ACS Omega 10:306\u2013317","journal-title":"ACS Omega"},{"key":"4757_CR8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijbiomac.2017.04.098","volume":"102","author":"S Das","year":"2017","unstructured":"Das S, Ghosh S, De AK, Bera T (2017) Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with Chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis. Int J Biol Macromol 102:996\u20131008","journal-title":"Int J Biol Macromol"},{"key":"4757_CR9","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.toxrep.2025.101900","volume":"14","author":"R Arulnangai","year":"2025","unstructured":"Arulnangai R, Asia Thabassoom H, Vajiha Banu H et al (2025) Recent developments on ursolic acid and its potential biological applications. Toxicol Rep 14:101900","journal-title":"Toxicol Rep"},{"key":"4757_CR10","doi-asserted-by":"publisher","first-page":"e0144946","DOI":"10.1371\/journal.pone.0144946","volume":"10","author":"ES Yamamoto","year":"2015","unstructured":"Yamamoto ES, Campos BLS, Jesus JA et al (2015) The effect of ursolic acid on leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis. PLoS ONE 10:e0144946","journal-title":"PLoS ONE"},{"key":"4757_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/pat.1710","volume":"22","author":"S Das","year":"2011","unstructured":"Das S, Khan W, Mohsin S, Kumar N (2011) Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation. Polym Adv Technol 22:172\u2013179","journal-title":"Polym Adv Technol"},{"key":"4757_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1039\/C5CS00674K","volume":"45","author":"V Guti\u00e9rrez","year":"2016","unstructured":"Guti\u00e9rrez V, Seabra AB, Reguera RM et al (2016) New approaches from nanomedicine for treating leishmaniasis. Chem Soc Rev 45:152\u2013168","journal-title":"Chem Soc Rev"},{"key":"4757_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1021\/acs.molpharmaceut.3c00918","volume":"21","author":"SS Sikandar","year":"2024","unstructured":"Sikandar SS, Kumar D, Rathod AG et al (2024) Sugar-based cryoprotectants stabilize liposomal vesicles by exhibiting a cholesterol-like effect. Mol Pharm 21:813\u2013821","journal-title":"Mol Pharm"},{"key":"4757_CR14","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s00436-022-07659-5","volume":"121","author":"FF Tuon","year":"2022","unstructured":"Tuon FF, Dantas LR, de Souza RM et al (2022) Liposomal drug delivery systems for the treatment of leishmaniasis. Parasitol Res 121:3073\u20133082","journal-title":"Parasitol Res"},{"key":"4757_CR15","doi-asserted-by":"crossref","unstructured":"Bhattacharjee S, Harithasree V, Mourya A et al (2024) Hyaluronic acid hydrogel in therapeutics delivery and biomedical applications. In: Jan S (ed) Biomaterial-based hydrogels: therapeutics carrier and tissue regeneration. Springer, pp 139\u2013177","DOI":"10.1007\/978-981-99-8826-6_6"},{"key":"4757_CR16","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1039\/D1BM01769A","volume":"10","author":"R Silva-Carvalho","year":"2022","unstructured":"Silva-Carvalho R, Le\u00e3o T, Bourbon AI et al (2022) Hyaluronic acid\u2013amphotericin B nanocomplexes: a promising anti-leishmanial drug delivery system. Biomater Sci 10:1952\u20131967","journal-title":"Biomater Sci"},{"key":"4757_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1021\/acs.biomac.1c01451","volume":"23","author":"R Silva-Carvalho","year":"2022","unstructured":"Silva-Carvalho R, Leao T, Gama FM, Tomas AM (2022) Covalent conjugation of amphotericin B to hyaluronic acid: an injectable water-soluble conjugate with reduced toxicity and Anti-Leishmanial potential. Biomacromolecules 23:1169\u20131182","journal-title":"Biomacromolecules"},{"key":"4757_CR18","doi-asserted-by":"publisher","first-page":"106451","DOI":"10.1016\/j.jddst.2024.106451","volume":"104","author":"R Sharma","year":"2025","unstructured":"Sharma R, Yadav V, Katari O, Jain S (2025) Hyaluronic acid functionalized liposomes for co-delivery of Paclitaxel and ursolic acid for enhanced efficacy against triple negative breast cancer. J Drug Deliv Sci Technol 104:106451","journal-title":"J Drug Deliv Sci Technol"},{"key":"4757_CR19","doi-asserted-by":"publisher","first-page":"115981","DOI":"10.1016\/j.carbpol.2020.115981","volume":"235","author":"J Wang","year":"2020","unstructured":"Wang J, Liu D, Guan S et al (2020) Hyaluronic acid-modified liposomal Honokiol nanocarrier: enhance anti-metastasis and antitumor efficacy against breast cancer. Carbohydr Polym 235:115981","journal-title":"Carbohydr Polym"},{"key":"4757_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1208\/s12249-013-0028-0","volume":"15","author":"J Song","year":"2014","unstructured":"Song J, Wang Y, Song Y et al (2014) Development and characterisation of ursolic acid nanocrystals without stabiliser having improved dissolution rate and in vitro anticancer activity. AAPS PharmSciTech 15:11\u201319","journal-title":"AAPS PharmSciTech"},{"key":"4757_CR21","doi-asserted-by":"publisher","first-page":"105399","DOI":"10.1016\/j.jddst.2024.105399","volume":"92","author":"A Mourya","year":"2024","unstructured":"Mourya A, Famta P, Shah S et al (2024) Raloxifene loaded d-\u03b1-tocopherol Polyethylene glycol 1000 succinate stabilized Poly (\u03b5-caprolactone) nanoparticles augmented drug delivery and apoptosis in breast cancer cells. J Drug Deliv Sci Technol 92:105399","journal-title":"J Drug Deliv Sci Technol"},{"key":"4757_CR22","doi-asserted-by":"publisher","first-page":"104453","DOI":"10.1016\/j.jddst.2023.104453","volume":"84","author":"K Charankumar","year":"2023","unstructured":"Charankumar K, Bagasariya D, Jain N et al (2023) Quality by design (QbD) abetted development of Pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma. J Drug Deliv Sci Technol 84:104453","journal-title":"J Drug Deliv Sci Technol"},{"key":"4757_CR23","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11095-014-1353-z","volume":"31","author":"H Xu","year":"2014","unstructured":"Xu H, Paxton J, Lim J et al (2014) Development of high-content gemcitabine pegylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells. Pharm Res 31:2583\u20132592","journal-title":"Pharm Res"},{"key":"4757_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.msec.2015.04.022","volume":"53","author":"T Zhao","year":"2015","unstructured":"Zhao T, Liu Y, Gao Z et al (2015) Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes. Mater Sci Eng C 53:196\u2013203","journal-title":"Mater Sci Eng C"},{"key":"4757_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.14227\/DT290422P204","volume":"29","author":"DM D\u2019Arcy","year":"2022","unstructured":"D\u2019Arcy DM, Wacker MG, Klein S et al (2022) In-vitro product performance of parenteral drug products: view of the USP expert panel. Dissolut Technol 29:204\u2013218","journal-title":"Dissolut Technol"},{"key":"4757_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12247-025-10110-8","volume":"20","author":"S Gollapalli","year":"2025","unstructured":"Gollapalli S, Sayyed S, Loharkar S et al (2025) Ursolic acid emulgel augmented drug delivery in leishmania Donovani, A causative agent for cutaneous leishmaniasis: in vitro characterization and Anti-Amastigote activity. J Pharm Innov 20:1\u201319","journal-title":"J Pharm Innov"},{"key":"4757_CR27","doi-asserted-by":"publisher","first-page":"115863","DOI":"10.1016\/j.ejmech.2023.115863","volume":"261","author":"S Katiyar","year":"2023","unstructured":"Katiyar S, Ramalingam K, Kumar A et al (2023) Design, synthesis, and biological evaluation of quinoline-piperazine\/pyrrolidine derivatives as possible antileishmanial agents. Eur J Med Chem 261:115863","journal-title":"Eur J Med Chem"},{"key":"4757_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijpddr.2016.01.001","volume":"6","author":"S Pandya","year":"2016","unstructured":"Pandya S, Verma RK, Khare P et al (2016) Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B. Int J Parasitol Drugs Drug Resist 6:125\u2013132","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"4757_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijbiomac.2020.03.019","volume":"153","author":"R Silva-Carvalho","year":"2020","unstructured":"Silva-Carvalho R, Fidalgo J, Melo KR et al (2020) Development of dextrin-amphotericin B formulations for the treatment of leishmaniasis. Int J Biol Macromol 153:276\u2013288","journal-title":"Int J Biol Macromol"},{"key":"4757_CR30","doi-asserted-by":"publisher","first-page":"139445","DOI":"10.1016\/j.cej.2022.139445","volume":"452","author":"R Chen","year":"2023","unstructured":"Chen R, Lin X, Wang Q et al (2023) Dual-targeting celecoxib nanoparticles protect intestinal epithelium and regulate macrophage polarization for ulcerative colitis treatment. Chem Eng J 452:139445","journal-title":"Chem Eng J"},{"key":"4757_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"4757_CR32","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D et al (2021) OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17:4291\u20134300","journal-title":"J Chem Theory Comput"},{"key":"4757_CR33","doi-asserted-by":"publisher","first-page":"141375","DOI":"10.1016\/j.molstruc.2025.141375","volume":"1328","author":"HMC Mouli","year":"2025","unstructured":"Mouli HMC, Harini D, Shaikh N et al (2025) In Silico characterization of indole-substituted densely functionalized pyrrole against breast cancer: integrating DFT, molecular docking, MD simulations, and ADME analysis. J Mol Struct 1328:141375","journal-title":"J Mol Struct"},{"key":"4757_CR34","unstructured":"Alzate MAH, Nogueira Filho MAF, Franchin TB et al (2019) Kinetic disposition of ursolic acid in rats. Pharm Biomed Res"},{"key":"4757_CR35","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1021\/jf405675g","volume":"62","author":"G Yang","year":"2014","unstructured":"Yang G, Yang T, Zhang W et al (2014) In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. J Agric Food Chem 62:2207\u20132215","journal-title":"J Agric Food Chem"},{"key":"4757_CR36","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/pharmaceutics12121164","volume":"12","author":"Z N\u00e9meth","year":"2020","unstructured":"N\u00e9meth Z, Pallagi E, Dob\u00f3 DG, Cs\u00f3ka I (2020) A proposed methodology for a risk assessment-based liposome development process. Pharmaceutics 12:1164","journal-title":"Pharmaceutics"},{"key":"4757_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","volume":"229","author":"F Ravar","year":"2016","unstructured":"Ravar F, Saadat E, Gholami M et al (2016) Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release 229:10\u201322","journal-title":"J Control Release"},{"key":"4757_CR38","doi-asserted-by":"publisher","first-page":"15053","DOI":"10.1080\/07391102.2023.2186710","volume":"41","author":"AS Shaikh","year":"2023","unstructured":"Shaikh AS, Sethi A, Makhal PN et al (2023) Quest for selective MMP9 inhibitors: a computational approach. J Biomol Struct Dyn 41:15053\u201315066","journal-title":"J Biomol Struct Dyn"},{"key":"4757_CR39","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1208\/s12249-016-0553-8","volume":"18","author":"SN Patere","year":"2017","unstructured":"Patere SN, Pathak PO, Kumar Shukla A et al (2017) Surface-modified liposomal formulation of amphotericin B: in vitro evaluation of potential against visceral leishmaniasis. AAPS PharmSciTech 18:710\u2013720","journal-title":"AAPS PharmSciTech"},{"key":"4757_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/515085","volume":"28","author":"A Meyerhoff","year":"1999","unstructured":"Meyerhoff A (1999) US food and drug administration approval of ambisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 28:42\u201348","journal-title":"Clin Infect Dis"},{"key":"4757_CR41","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1038\/s41598-023-31560-5","volume":"13","author":"A Miatmoko","year":"2023","unstructured":"Miatmoko A, Asmoro FH, Azhari AA et al (2023) The effect of 1, 2-dioleoyl-3-trimethylammonium propane (DOTAP) addition on the physical characteristics of \u03b2-ionone liposomes. Sci Rep 13:4324","journal-title":"Sci Rep"},{"key":"4757_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpb.2015.06.026","volume":"94","author":"PC Soema","year":"2015","unstructured":"Soema PC, Willems G-J, Jiskoot W et al (2015) Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. Eur J Pharm Biopharm 94:427\u2013435","journal-title":"Eur J Pharm Biopharm"},{"key":"4757_CR43","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.devcel.2012.10.009","volume":"23","author":"J Bigay","year":"2012","unstructured":"Bigay J, Antonny B (2012) Curvature, lipid Packing, and electrostatics of membrane organelles: defining cellular territories in determining specificity. Dev Cell 23:886\u2013895","journal-title":"Dev Cell"},{"key":"4757_CR44","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","volume":"409","author":"MC Smith","year":"2017","unstructured":"Smith MC, Crist RM, Clogston JD, McNeil SE (2017) Zeta potential: a case study of cationic, anionic, and neutral liposomes. Anal Bioanal Chem 409:5779\u20135787","journal-title":"Anal Bioanal Chem"},{"key":"4757_CR45","doi-asserted-by":"publisher","first-page":"125881","DOI":"10.1016\/j.ijpharm.2025.125881","volume":"681","author":"F Zhao","year":"2025","unstructured":"Zhao F, Nayyar D, Hwang YS et al (2025) Effect of positive charges on liposome stability, uptake efficacy and impact on cells. Int J Pharm 681:125881","journal-title":"Int J Pharm"},{"key":"4757_CR46","doi-asserted-by":"publisher","first-page":"117572","DOI":"10.1016\/j.carbpol.2020.117572","volume":"257","author":"D Liu","year":"2021","unstructured":"Liu D, Zhang Q, Wang J et al (2021) Inhibition of growth and metastasis of breast cancer by targeted delivery of 17-hydroxy-jolkinolide B via hyaluronic acid-coated liposomes. Carbohydr Polym 257:117572","journal-title":"Carbohydr Polym"},{"key":"4757_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.msec.2016.11.014","volume":"71","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao T, Liu Y et al (2017) Ursolic acid liposomes with Chitosan modification: promising antitumor drug delivery and efficacy. Mater Sci Eng C 71:1231\u20131240","journal-title":"Mater Sci Eng C"},{"key":"4757_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.chemphyslip.2016.10.005","volume":"201","author":"A Jain","year":"2016","unstructured":"Jain A, Jain SK (2016) In vitro release kinetics model fitting of liposomes: an insight. Chem Phys Lipids 201:28\u201340","journal-title":"Chem Phys Lipids"},{"key":"4757_CR49","doi-asserted-by":"crossref","unstructured":"Madhukar P, Kesarwani R, Pandey S et al (2025) Amine-Functionalized Graphene Quantum Dots Conjugated with Amphotericin B: Synthesis, Characterization, and In Vitro Evaluation for Visceral Leishmaniasis Treatment. ACS Omega","DOI":"10.1021\/acsomega.5c00879"},{"key":"4757_CR50","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/pharmaceutics14081590","volume":"14","author":"S Jain","year":"2022","unstructured":"Jain S, Sahu U, Kumar A, Khare P (2022) Metabolic pathways of leishmania parasite: source of pertinent drug targets and potent drug candidates. Pharmaceutics 14:1590","journal-title":"Pharmaceutics"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04757-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:01:55Z","timestamp":1776747715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04757-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4757"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04757-w","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors accepted for publication of the submitted manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"182"}}